142 related articles for article (PubMed ID: 24594238)
1. Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.
Belkhribchia MR; Collet C; Laplanche JL; Hassani R
Eur J Med Genet; 2014 Mar; 57(4):133-7. PubMed ID: 24594238
[TBL] [Abstract][Full Text] [Related]
2. Novel SOST gene mutation in a sclerosteosis patient and her parents.
Bhadada SK; Rastogi A; Steenackers E; Boudin E; Arya A; Dhiman V; Bhansali A; Van Hul W
Bone; 2013 Feb; 52(2):707-10. PubMed ID: 23079137
[TBL] [Abstract][Full Text] [Related]
3. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.
Whyte MP; Deepak Amalnath S; McAlister WH; Pedapati R; Muthupillai V; Duan S; Huskey M; Bijanki VN; Mumm S
Bone; 2018 Nov; 116():321-332. PubMed ID: 30077757
[TBL] [Abstract][Full Text] [Related]
4. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.
Fayez A; Aglan M; Esmaiel N; El Zanaty T; Abdel Kader M; El Ruby M
Biomed Res Int; 2015; 2015():517815. PubMed ID: 25984533
[TBL] [Abstract][Full Text] [Related]
5. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family.
He WT; Chen C; Pan C; Zhang MX; Yu XF; Wang DW; Hu SH
Clin Genet; 2016 Feb; 89(2):205-9. PubMed ID: 26283468
[TBL] [Abstract][Full Text] [Related]
6. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
Sebastian A; Loots GG
Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
[TBL] [Abstract][Full Text] [Related]
7. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.
Piters E; Culha C; Moester M; Van Bezooijen R; Adriaensen D; Mueller T; Weidauer S; Jennes K; de Freitas F; Löwik C; Timmermans JP; Van Hul W; Papapoulos S
Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295
[TBL] [Abstract][Full Text] [Related]
8. A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.
Kim CA; Honjo R; Bertola D; Albano L; Oliveira L; Jales S; Siqueira J; Castilho A; Balemans W; Piters E; Jennes K; Van Hul W
Genet Test; 2008 Dec; 12(4):475-9. PubMed ID: 19072561
[TBL] [Abstract][Full Text] [Related]
9. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.
Balemans W; Cleiren E; Siebers U; Horst J; Van Hul W
Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.
Ekhzaimy AA; Alyusuf EY; Alswailem M; Alzahrani AS
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208525
[No Abstract] [Full Text] [Related]
11. The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans.
Boudin E; Yorgan T; Fijalkowski I; Sonntag S; Steenackers E; Hendrickx G; Peeters S; De Maré A; Vervaet B; Verhulst A; Mortier G; D'Haese P; Schinke T; Van Hul W
J Bone Miner Res; 2017 Aug; 32(8):1739-1749. PubMed ID: 28477420
[TBL] [Abstract][Full Text] [Related]
12. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
[TBL] [Abstract][Full Text] [Related]
13. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
[TBL] [Abstract][Full Text] [Related]
15. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
16. Anatomical similarity between the Sost-knockout mouse and sclerosteosis in humans.
Schwarze UY; Dobsak T; Gruber R; Bookstein FL
Anat Rec (Hoboken); 2020 Sep; 303(9):2295-2308. PubMed ID: 31729194
[TBL] [Abstract][Full Text] [Related]
17. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
Balemans W; Ebeling M; Patel N; Van Hul E; Olson P; Dioszegi M; Lacza C; Wuyts W; Van Den Ende J; Willems P; Paes-Alves AF; Hill S; Bueno M; Ramos FJ; Tacconi P; Dikkers FG; Stratakis C; Lindpaintner K; Vickery B; Foernzler D; Van Hul W
Hum Mol Genet; 2001 Mar; 10(5):537-43. PubMed ID: 11181578
[TBL] [Abstract][Full Text] [Related]
18. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
19. The natural history of sclerosteosis.
Hamersma H; Gardner J; Beighton P
Clin Genet; 2003 Mar; 63(3):192-7. PubMed ID: 12694228
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin deficiency is linked to altered bone composition.
Hassler N; Roschger A; Gamsjaeger S; Kramer I; Lueger S; van Lierop A; Roschger P; Klaushofer K; Paschalis EP; Kneissel M; Papapoulos S
J Bone Miner Res; 2014 Oct; 29(10):2144-51. PubMed ID: 24753092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
